Sensient Technologies Corp 8-K, filed Feb 11, 2022
Sensient Technologies Corp (SXT)
8-K
2022-02-11
For: 2022-02-11
View Original
Added on
April 10, 2026
About this 8-K
Sensient Technologies Corp filed this 8-K on February 11, 2022.
Items reported
- Item 2.02: Financial results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
(Date of Report/Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
(Address and zip code of principal executive offices)
(414 ) 271-6755
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02 |
Results of Operations and Financial Condition.
|
Sensient Technologies Corporation (the “Company”) issued a press release on February 11, 2022 disclosing its results of operations for its quarter and year ended December
31, 2021, and its financial condition at that date. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this Item 2.02 (including Exhibit 99.1) is intended to be furnished under Item 2.02 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed under the
Securities Act of 1933, as amended, or the Exchange Act.
| Item 7.01 |
Regulation FD Disclosure.
|
On February
11, 2022, the Company also posted an updated investor presentation for its quarter and year ended December 31, 2021 on the “Investor Information” section of its
website. A copy of the investor presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
The information contained in this Item 7.01 (including Exhibit 99.2) is intended to be furnished under Item 7.01 of Form 8-K and shall not be deemed
“filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed under the Securities Act
of 1933, as amended, or the Exchange Act.
| Item 9.01 |
Financial Statements and Exhibits.
|
| (d) |
Exhibits. The following exhibits are furnished with this Current Report on Form 8-K:
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
Sensient Technologies Corporation Earnings Press Release for the Quarter and Year Ended December 31, 2021.
|
|
|
Sensient Technologies Corporation Investor Presentation – Q4 2021.
|
|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
SENSIENT TECHNOLOGIES CORPORATION
|
|||
|
By:
|
/s/ John J. Manning
|
||
|
Name:
|
John J. Manning
|
||
|
Title:
|
Senior Vice President, General Counsel, and Secretary
|
||
|
Date:
|
February 11, 2022
|
||
Exhibit 99.1
|
Contact:
|
Amy Agallar
|
|
(414) 347-3706
|
Sensient Technologies Corporation
Reports Results for the Quarter Ended December 31, 2021
Reported Consolidated Revenue Growth of 1.7%
Adjusted Consolidated Local Currency Revenue Growth of 10.7%
Flavors & Extracts Continues its Strong Performance
Color and Asia Pacific Groups Report Double Digit Revenue and Profit Growth
MILWAUKEE— February 11, 2022 — Sensient Technologies Corporation (NYSE: SXT) reported consolidated revenue of $340.4 million in this year’s fourth quarter compared to
$334.7 million in last year’s fourth quarter. Reported operating income in the fourth quarter of 2021 was $40.4 million compared to $34.8 million in the fourth quarter of 2020. Reported diluted earnings per share was 65 cents in the fourth quarter of
2021 compared to 59 cents in the fourth quarter of 2020. Foreign currency translation decreased revenue by approximately 1% and earnings per share by approximately 2% in the quarter.
The 2021 fourth quarter reported results include divestiture & other related costs and operational improvement plan costs, which in total decreased
fourth quarter net earnings by $3.0 million ($0.07 per diluted share). The 2020 fourth quarter reported results include divestiture & other related costs, operational improvement plan costs, and a one-time COVID-19 employee payment, which in
total decreased net earnings by $3.2 million ($0.07 per diluted share). The 2021 and 2020 fourth quarter reported results also include the operations of the divested product lines, which increased revenue by $0.7 million and $25.2 million in 2021 and
2020, respectively. The operations of the divested product lines also decreased diluted earnings per share by $0.01 in the fourth quarter of 2021 and increased diluted earnings per share by $0.06 in the fourth quarter of 2020. The adjustments to our
reported results are described in more detail under “Reconciliation of Non-GAAP Amounts” at the end of this release.
|
Sensient Technologies Corporation
|
Page 2
|
|
Earnings Release – Quarter Ended December 31, 2021
|
|
|
February 11, 2022
|
|
BUSINESS REVIEW
|
Reported
|
||||||||
|
Revenue
|
Quarter
|
Year-to-Date
|
||||||
|
Flavors & Extracts
|
-6.1%
|
-0.4%
|
||||||
|
Color
|
14.4%
|
8.8%
|
||||||
|
Asia Pacific
|
11.1%
|
11.6%
|
||||||
|
Total Revenue
|
1.7%
|
3.6%
|
||||||
|
Adjusted
Local Currency (1)
|
||||||||
|
Revenue
|
Quarter
|
Year-to-Date
|
||||||
|
Flavors & Extracts
|
8.0%
|
|
9.4%
|
|||||
|
Color
|
15.8%
|
9.4%
|
||||||
|
Asia Pacific
|
15.0%
|
|
10.1%
|
|||||
|
Total Revenue
|
10.7%
|
|
9.1%
|
|||||
|
(1) Adjusted local currency percentage changes are described in more detail in the “Reconciliation of Non-GAAP Amounts” at the end of this release.
|
||||||||
The Flavors & Extracts Group reported fourth quarter revenue of $177.4 million compared to $189.1 million reported in the comparable period last
year, a decrease of 6.1%, primarily due to the divestiture of the Fragrances product line in April 2021. Adjusted local currency revenue increased 8.0% in the quarter. The higher adjusted local currency revenue was primarily the result of favorable
pricing and volume growth. Segment operating income was $21.9 million in the current quarter compared to $23.5 million reported in the comparable period last year, a decrease of 6.7%, primarily due to the divestiture of the Fragrance product line.
Adjusted local currency operating income increased 10.6% in the quarter. The higher adjusted local currency operating income was primarily due to the favorable pricing and higher volumes. Foreign currency translation decreased both segment revenue
and operating income by approximately 1% in the quarter.
| Sensient Technologies Corporation | Page 3 |
|
Earnings Release – Quarter Ended December 31, 2021
|
|
|
February 11, 2022
|
The Color Group reported revenue of $137.1 million in the quarter compared to $119.8 million in last year’s comparable period, an increase of 14.4%.
Adjusted local currency revenue increased 15.8% in the quarter. The Group experienced strong volume growth in both Food & Pharmaceutical Colors and Personal Care. Segment operating income was $24.1 million in the quarter compared to $20.5 million
in last year’s comparable period, an increase of 17.3%. Adjusted local currency operating income increased 19.1% compared to the prior year’s fourth quarter. The higher operating income is primarily a result of the higher volumes. Foreign currency
translation decreased both segment revenue and operating income by approximately 1% in the quarter.
The Asia Pacific Group reported revenue of $35.7 million in the quarter compared to $32.2 million in last year’s comparable period, an increase of
11.1%. Adjusted local currency revenue increased 15.0% in the quarter. Segment operating income was $7.2 million in the quarter compared to $6.0 million in last year’s comparable quarter, an increase of 18.9%. Adjusted local currency operating income
increased 24.9% in the quarter. The higher profit was primarily a result of the favorable volume growth. Foreign currency translation decreased segment revenue and operating income by approximately 4% and 5%, respectively, in the quarter.
Corporate & Other reported operating costs of $12.8 million in the current quarter compared to $15.3 million in last year’s comparable period, a
decrease of 16.1%. The lower costs are primarily due to the one-time COVID-19 employee payment in the fourth quarter of 2020. Adjusted local currency operating expenses for Corporate & Other increased 22.1% in the quarter primarily due to higher
performance-based compensation.
|
Sensient Technologies Corporation
|
Page 4 |
|
Earnings Release – Quarter Ended December 31, 2021
|
|
|
February 11, 2022
|
2022 OUTLOOK
Sensient expects 2022 full year GAAP diluted earnings per share to grow at a mid-teen growth rate compared to the Company’s 2021 reported GAAP diluted
earnings per share of $2.81. Our full year 2022 guidance does not include any material divestiture related costs, operational improvement plan costs, or results of divested businesses.
The Company expects 2022 local currency revenue to grow at a mid-single-digit rate compared to the Company’s 2021 adjusted revenue (2). The
Company expects 2022 local currency adjusted EBITDA(2) and local currency diluted earnings per share to grow at a high single-digit rate compared to the Company’s 2021 adjusted EBITDA(2) and the Company’s 2021 adjusted diluted
earnings per share(2) of $3.13, respectively.
The Company expects earnings per share reported on a U.S. dollar basis to be impacted by approximately ten cents of foreign currency headwinds based
on current exchange rates.
The Company’s guidance is based upon current trends, current tax law, and the effects of COVID-19 to date. The full impacts of the ongoing COVID-19
pandemic remain uncertain and management will continue to monitor its impacts on our business.
| (2) |
See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information.
|
|
Sensient Technologies Corporation
|
Page 5
|
|
Earnings Release – Quarter Ended December 31, 2021
|
|
|
February 11, 2022
|
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include, currency movements,
depreciation and amortization, non-cash share-based compensation, divestiture & other related costs, operational improvement plan costs and income, the 2020 COVID-19 employee payment costs, and the results of the divested operations. These
measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2021 fourth quarter financial results at 8:30 a.m. CST on Friday, February 11, 2022. To
participate in the conference call, contact Chorus Call Inc. at (844) 492-3726 or (412) 317-1078, and ask to join the Sensient Technologies Corporation conference call. Alternatively, the call can be accessed by using the webcast link that is
available on the Investor Information section of the Company’s web site at www.sensient.com.
A replay of the call will be available one hour after the end of the conference call through February 18, 2022, by calling (877) 344-7529 and referring
to conference identification number 4903818. An audio replay and written transcript of the call will also be posted on the Investor Information section of the Company’s web site at www.sensient.com on or after February 15, 2022.
|
Sensient Technologies Corporation
|
Page 6
|
|
Earnings Release – Quarter Ended December 31, 2021
|
|
|
February 11, 2022
|
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws
including under “2022 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment.
Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and
uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost
of labor, logistics, and transportation, governmental regulations and restrictions, and general economic conditions, including inflation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s
ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction
efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic
factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by
competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and in other documents that the Company files with the SEC, including the
Company’s Annual Report on Form 10-K for the year ended December 31, 2021 that will be filed by March 1, 2022. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and uncertainties not presently
known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have material adverse effects on our
business, financial condition, and results of operations. This release contains time-sensitive information that reflects management’s best analysis only as of the date of this release. Except to the extent required by applicable laws, the Company
does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be realized.
ABOUT SENSIENT TECHNOLOGIES
Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses
advanced technologies and robust global supply chain capabilities to develop specialized solutions for food and beverages, as well as products that serve the pharmaceutical, nutraceutical, cosmetic, and personal care industries. Sensient’s customers
range in size from small entrepreneurial businesses to major international manufacturers representing some of the world’s best-known brands. Sensient is headquartered in Milwaukee, Wisconsin.
www.sensient.com
|
Sensient Technologies Corporation
|
Page 7
|
|
(In thousands, except percentages and per share amounts)
|
|
|
(Unaudited)
|
|
|
Consolidated Statements of Earnings
|
Three Months Ended December 31,
|
Year Ended December 31,
|
||||||||||||||||||||||
|
2021
|
2020
|
% Change
|
2021
|
2020
|
% Change
|
|||||||||||||||||||
|
Revenue
|
$
|
340,448
|
$
|
334,668
|
1.7%
|
|
$
|
1,380,264
|
$
|
1,332,001
|
3.6%
|
|
||||||||||||
|
Cost of products sold
|
228,065
|
230,674
|
(1.1%)
|
|
925,603
|
908,254
|
1.9%
|
|
||||||||||||||||
|
Selling and administrative expenses
|
71,963
|
69,179
|
4.0%
|
|
284,633
|
271,091
|
5.0%
|
|
||||||||||||||||
|
Operating income
|
40,420
|
34,815
|
16.1%
|
|
170,028
|
152,656
|
11.4%
|
|
||||||||||||||||
|
Interest expense
|
2,752
|
3,399
|
12,544
|
14,811
|
||||||||||||||||||||
|
Earnings before income taxes
|
37,668
|
31,416
|
157,484
|
137,845
|
||||||||||||||||||||
|
Income taxes
|
10,439
|
6,247
|
38,739
|
28,373
|
||||||||||||||||||||
|
Net earnings
|
$
|
27,229
|
$
|
25,169
|
8.2%
|
|
$
|
118,745
|
$
|
109,472
|
8.5%
|
|
||||||||||||
|
Earnings per share of common stock:
|
||||||||||||||||||||||||
|
Basic
|
$
|
0.65
|
$
|
0.59
|
$
|
2.82
|
$
|
2.59
|
||||||||||||||||
|
|
||||||||||||||||||||||||
|
Diluted
|
$
|
0.65
|
$
|
0.59
|
$
|
2.81
|
$
|
2.59
|
||||||||||||||||
|
Average common shares outstanding:
|
||||||||||||||||||||||||
|
Basic
|
41,890
|
42,307
|
42,077
|
42,301
|
||||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Diluted
|
42,173
|
42,404
|
42,258
|
42,346
|
||||||||||||||||||||
|
Results by Segment
|
Three Months Ended December 31,
|
Year Ended December 31,
|
||||||||||||||||||||||
|
Revenue
|
2021
|
2020
|
% Change
|
2021
|
2020
|
% Change
|
||||||||||||||||||
|
Flavors & Extracts
|
$
|
177,448
|
$
|
189,060
|
(6.1%)
|
|
$
|
739,427
|
$
|
742,035
|
(0.4%)
|
|
||||||||||||
|
Color
|
137,104
|
119,813
|
14.4%
|
|
545,270
|
501,018
|
8.8%
|
|
||||||||||||||||
|
Asia Pacific
|
35,749
|
32,165
|
11.1%
|
135,348
|
121,227
|
11.6%
|
||||||||||||||||||
|
Intersegment elimination
|
(9,853
|
)
|
(6,370
|
)
|
(39,781
|
)
|
(32,279
|
)
|
||||||||||||||||
|
Consolidated
|
$
|
340,448
|
$
|
334,668
|
1.7%
|
$
|
1,380,264
|
$
|
1,332,001
|
3.6%
|
||||||||||||||
|
Operating Income
|
||||||||||||||||||||||||
|
Flavors & Extracts
|
$
|
21,942
|
$
|
23,507
|
(6.7%)
|
$
|
98,660
|
$
|
90,974
|
8.4%
|
||||||||||||||
|
Color
|
24,113
|
20,548
|
17.3%
|
103,575
|
96,034
|
7.9%
|
||||||||||||||||||
|
Asia Pacific
|
7,184
|
6,044
|
18.9%
|
26,330
|
22,075
|
19.3%
|
||||||||||||||||||
|
Corporate & Other
|
(12,819
|
)
|
(15,284
|
)
|
(58,537
|
)
|
(56,427
|
)
|
||||||||||||||||
|
Consolidated
|
$
|
40,420
|
$
|
34,815
|
16.1%
|
$
|
170,028
|
$
|
152,656
|
11.4%
|
||||||||||||||
|
Sensient Technologies Corporation
|
Page 8
|
|
(In thousands)
|
|
|
(Unaudited)
|
|
|
Consolidated Condensed Balance Sheets
|
December 31,
2021
|
December 31,
2020
|
||||||
|
Cash and cash equivalents
|
$
|
25,740
|
$
|
24,770
|
||||
|
Trade accounts receivable
|
261,121
|
234,132
|
||||||
|
Inventories
|
411,635
|
381,346
|
||||||
|
Prepaid expenses and other current assets
|
42,657
|
48,578
|
||||||
|
Assets held for sale
|
-
|
52,760
|
||||||
|
Total Current Assets
|
741,153
|
741,586
|
||||||
|
Goodwill & intangible assets (net)
|
435,009
|
434,220
|
||||||
|
Property, plant, and equipment (net)
|
446,478
|
445,493
|
||||||
|
Other assets
|
122,853
|
119,561
|
||||||
|
Total Assets
|
$
|
1,745,493
|
$
|
1,740,860
|
||||
|
Trade accounts payable
|
$
|
125,519
|
$
|
107,324
|
||||
|
Short-term borrowings
|
8,539
|
9,247
|
||||||
|
Other current liabilities
|
98,247
|
82,045
|
||||||
|
Liabilities held for sale
|
-
|
17,339
|
||||||
|
Total Current Liabilities
|
232,305
|
215,955
|
||||||
|
Long-term debt
|
503,006
|
518,004
|
||||||
|
Accrued employee and retiree benefits
|
28,579
|
28,941
|
||||||
|
Other liabilities
|
43,178
|
43,624
|
||||||
|
Shareholders’ Equity
|
938,425
|
934,336
|
||||||
|
Total Liabilities and Shareholders’ Equity
|
$
|
1,745,493
|
$
|
1,740,860
|
||||
|
Sensient Technologies Corporation
|
Page 9
|
|
(In thousands, except per share amounts)
|
|
|
(Unaudited)
|
|
|
Consolidated Statements of Cash Flows
|
||||||||
|
Year Ended December 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net earnings
|
$
|
118,745
|
$
|
109,472
|
||||
|
Adjustments to arrive at net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
52,051
|
49,641
|
||||||
|
Share-based compensation expense
|
9,573
|
5,608
|
||||||
|
Net loss (gain) on assets
|
331
|
(252
|
)
|
|||||
|
Loss on divestitures and other charges
|
14,021
|
6,904
|
||||||
|
Deferred income taxes
|
(6,071
|
)
|
(8,705
|
)
|
||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Trade accounts receivable
|
(34,571
|
)
|
(11,357
|
)
|
||||
|
Inventories
|
(36,323
|
)
|
46,828
|
|||||
|
Prepaid expenses and other assets
|
(6,057
|
)
|
(12,868
|
)
|
||||
|
Trade accounts payable and other accrued expenses
|
21,326
|
15,524
|
||||||
|
Accrued salaries, wages, and withholdings from employees
|
7,321
|
15,140
|
||||||
|
Income taxes
|
4,275
|
22
|
||||||
|
Other liabilities
|
597
|
2,823
|
||||||
|
Net cash provided by operating activities
|
145,218
|
218,780
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Acquisition of property, plant, and equipment
|
(60,788
|
)
|
(52,162
|
)
|
||||
|
Proceeds from sale of assets
|
216
|
1,075
|
||||||
|
Proceeds from divestiture of businesses
|
37,790
|
12,595
|
||||||
|
Acquisition of new business
|
(13,875
|
)
|
-
|
|||||
|
Other investing activities
|
1,097
|
5,071
|
||||||
|
Net cash used in investing activities
|
(35,560
|
)
|
(33,421
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from additional borrowings
|
112,194
|
36,667
|
||||||
|
Debt payments
|
(110,168
|
)
|
(154,348
|
)
|
||||
|
Purchase of treasury stock
|
(42,511
|
)
|
-
|
|||||
|
Dividends paid
|
(66,694
|
)
|
(66,057
|
)
|
||||
|
Other financing activities
|
(582
|
)
|
(415
|
)
|
||||
|
Net cash used in financing activities
|
(107,761
|
)
|
(184,153
|
)
|
||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(927
|
)
|
2,411
|
|||||
|
Net increase in cash and cash equivalents
|
970
|
3,617
|
||||||
|
Cash and cash equivalents at beginning of period
|
24,770
|
21,153
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
25,740
|
$
|
24,770
|
||||
|
Supplemental Information
Year Ended December 31,
|
2021
|
2020
|
||||||
|
Dividends paid per share
|
$
|
1.58
|
$
|
1.56
|
||||
|
Sensient Technologies Corporation
|
Page 10
|
|
(In thousands, except percentages and per share amounts)
|
|
|
(Unaudited)
|
|
Reconciliation of Non-GAAP Amounts
The Company’s results for the three and twelve months ended December 31, 2021 and 2020 include adjusted revenue, adjusted operating income, adjusted net earnings, and
adjusted diluted earnings per share, which exclude divestiture & other related costs, operational improvement plan costs and income, the results of the divested operations, and the 2020 COVID-19 employee payment.
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||||||||||
|
2021
|
2020
|
% Change
|
2021
|
2020
|
% Change
|
|||||||||||||||||||
|
Revenue (GAAP)
|
$
|
340,448
|
$
|
334,668
|
1.7%
|
$
|
1,380,264
|
$
|
1,332,001
|
3.6%
|
||||||||||||||
|
Revenue of the divested product lines
|
(663
|
)
|
(25,163
|
)
|
(30,062
|
)
|
(113,553
|
)
|
||||||||||||||||
|
Adjusted revenue
|
$
|
339,785
|
$
|
309,505
|
9.8%
|
$
|
1,350,202
|
$
|
1,218,448
|
10.8%
|
||||||||||||||
|
Operating income (GAAP)
|
$
|
40,420
|
$
|
34,815
|
16.1%
|
$
|
170,028
|
$
|
152,656
|
11.4%
|
||||||||||||||
|
Divestiture & other related costs – Cost of products sold
|
58
|
4
|
86
|
1,795
|
||||||||||||||||||||
|
Divestiture & other related costs – Selling and administrative expenses
|
579
|
1,671
|
14,052
|
10,360
|
||||||||||||||||||||
|
Operating loss (income) of the divested product lines
|
518
|
(3,415
|
)
|
(1,880
|
)
|
(7,580
|
)
|
|||||||||||||||||
|
Operational improvement plan - Cost of products sold
|
-
|
-
|
-
|
35
|
||||||||||||||||||||
|
Operational improvement plan - Selling and administrative
expenses (income)
|
115
|
698
|
(1,895
|
)
|
3,304
|
|||||||||||||||||||
|
COVID-19 employee payment - Cost of products sold
|
-
|
1,036
|
-
|
1,036
|
||||||||||||||||||||
|
COVID-19 employee payment - Selling and administrative expenses
|
-
|
1,986
|
-
|
1,986
|
||||||||||||||||||||
|
Adjusted operating income
|
$
|
41,690
|
$
|
36,795
|
13.3%
|
$
|
180,391
|
$
|
163,592
|
10.3%
|
||||||||||||||
|
Net earnings (GAAP)
|
$
|
27,229
|
$
|
25,169
|
8.2%
|
$
|
118,745
|
$
|
109,472
|
8.5%
|
||||||||||||||
|
Divestiture & other related costs, before tax
|
637
|
1,675
|
14,138
|
12,155
|
||||||||||||||||||||
|
Tax impact of divestiture & other related costs
|
1,809
|
(1,393
|
)
|
2,092
|
(2,605
|
)
|
||||||||||||||||||
|
Net loss (earnings) of the divested product lines, before tax
|
518
|
(3,415
|
)
|
(1,880
|
)
|
(7,580
|
)
|
|||||||||||||||||
|
Tax impact of the divested product lines
|
(130
|
)
|
790
|
460
|
1,945
|
|||||||||||||||||||
|
Operational improvement plan costs (income), before tax
|
115
|
698
|
(1,895
|
)
|
3,339
|
|||||||||||||||||||
|
Tax impact of operational improvement plan
|
427
|
(170
|
)
|
471
|
(826
|
)
|
||||||||||||||||||
|
COVID-19 employee payment, before tax
|
-
|
3,022
|
-
|
3,022
|
||||||||||||||||||||
|
Tax impact of COVID-19 employee payment
|
-
|
(675
|
)
|
-
|
(675
|
)
|
||||||||||||||||||
|
Adjusted net earnings
|
$
|
30,605
|
$
|
25,701
|
19.1%
|
$
|
132,131
|
$
|
118,247
|
11.7%
|
||||||||||||||
|
Diluted earnings per share (GAAP)
|
$
|
0.65
|
$
|
0.59
|
10.2%
|
$
|
2.81
|
$
|
2.59
|
8.5%
|
||||||||||||||
|
Divestiture & other related costs, net of tax
|
0.06
|
0.01
|
0.38
|
0.23
|
||||||||||||||||||||
|
Results of operations of the divested product lines, net of tax
|
0.01
|
(0.06
|
)
|
(0.03
|
)
|
(0.13
|
)
|
|||||||||||||||||
|
Operational improvement plan costs (income), net of tax
|
0.01
|
0.01
|
(0.03
|
)
|
0.06
|
|||||||||||||||||||
|
COVID-19 employee payment, net of tax
|
-
|
0.06
|
-
|
0.06
|
||||||||||||||||||||
|
Adjusted diluted earnings per share
|
$
|
0.73
|
$
|
0.61
|
19.7%
|
$
|
3.13
|
$
|
2.79
|
12.2%
|
||||||||||||||
Note: Earnings per share calculations may not foot due to rounding differences.
|
Sensient Technologies Corporation
|
Page 11
|
|
(In thousands)
|
|
|
(Unaudited)
|
|
Reconciliation of Non-GAAP Amounts - Continued
|
Results by Segment
|
Three Months Ended December 31,
|
|||||||||||||||||||||||
|
Adjusted
|
Adjusted
|
|||||||||||||||||||||||
|
Revenue
|
2021
|
Adjustments (1)
|
2021
|
2020
|
Adjustments (1)
|
2020
|
||||||||||||||||||
|
Flavors & Extracts
|
$
|
177,448
|
$
|
(221
|
)
|
$
|
177,227
|
$
|
189,060
|
$
|
(24,378
|
)
|
$
|
164,682
|
||||||||||
|
Color
|
137,104
|
(442
|
)
|
136,662
|
119,813
|
(766
|
)
|
119,047
|
||||||||||||||||
|
Asia Pacific
|
35,749
|
-
|
35,749
|
32,165
|
(116
|
)
|
32,049
|
|||||||||||||||||
|
Intersegment elimination
|
(9,853
|
)
|
-
|
(9,853
|
)
|
(6,370
|
)
|
97
|
(6,273
|
)
|
||||||||||||||
|
Consolidated
|
$
|
340,448
|
$
|
(663
|
)
|
$
|
339,785
|
$
|
334,668
|
$
|
(25,163
|
)
|
$
|
309,505
|
||||||||||
|
Operating Income
|
||||||||||||||||||||||||
|
Flavors & Extracts
|
$
|
21,942
|
$
|
491
|
$
|
22,433
|
$
|
23,507
|
$
|
(3,214
|
)
|
$
|
20,293
|
|||||||||||
|
Color
|
24,113
|
27
|
24,140
|
20,548
|
(158
|
)
|
20,390
|
|||||||||||||||||
|
Asia Pacific
|
7,184
|
-
|
7,184
|
6,044
|
(43
|
)
|
6,001
|
|||||||||||||||||
|
Corporate & Other
|
(12,819
|
)
|
752
|
(12,067
|
)
|
(15,284
|
)
|
5,395
|
(9,889
|
)
|
||||||||||||||
|
Consolidated
|
$
|
40,420
|
$
|
1,270
|
$
|
41,690
|
$
|
34,815
|
$
|
1,980
|
$
|
36,795
|
||||||||||||
|
Results by Segment
|
Year Ended December 31,
|
|||||||||||||||||||||||
|
Adjusted
|
Adjusted
|
|||||||||||||||||||||||
|
Revenue
|
2021
|
Adjustments (1)
|
2021
|
2020
|
Adjustments (1)
|
2020
|
||||||||||||||||||
|
Flavors & Extracts
|
$
|
739,427
|
$
|
(27,837
|
)
|
$
|
711,590
|
$
|
742,035
|
$
|
(99,543
|
)
|
$
|
642,492
|
||||||||||
|
Color
|
545,270
|
(2,080
|
)
|
543,190
|
501,018
|
(14,008
|
)
|
487,010
|
||||||||||||||||
|
Asia Pacific
|
135,348
|
(295
|
)
|
135,053
|
121,227
|
(518
|
)
|
120,709
|
||||||||||||||||
|
Intersegment elimination
|
(39,781
|
)
|
150
|
(39,631
|
)
|
(32,279
|
)
|
516
|
(31,763
|
)
|
||||||||||||||
|
Consolidated
|
$
|
1,380,264
|
$
|
(30,062
|
)
|
$
|
1,350,202
|
$
|
1,332,001
|
$
|
(113,553
|
)
|
$
|
1,218,448
|
||||||||||
|
Operating Income
|
||||||||||||||||||||||||
|
Flavors & Extracts
|
$
|
98,660
|
$
|
(2,368
|
)
|
$
|
96,292
|
$
|
90,974
|
$
|
(8,292
|
)
|
$
|
82,682
|
||||||||||
|
Color
|
103,575
|
575
|
104,150
|
96,034
|
871
|
96,905
|
||||||||||||||||||
|
Asia Pacific
|
26,330
|
(87
|
)
|
26,243
|
22,075
|
(159
|
)
|
21,916
|
||||||||||||||||
|
Corporate & Other
|
(58,537
|
)
|
12,243
|
(46,294
|
)
|
(56,427
|
)
|
18,516
|
(37,911
|
)
|
||||||||||||||
|
Consolidated
|
$
|
170,028
|
$
|
10,363
|
$
|
180,391
|
$
|
152,656
|
$
|
10,936
|
$
|
163,592
|
||||||||||||
| (1) |
For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs,
operational improvement plan costs and income, and the 2020 COVID-19 employee payment.
|
|
Sensient Technologies Corporation
|
Page 12
|
|
(In thousands, except percentages)
|
|
|
(Unaudited)
|
|
Reconciliation of Non-GAAP Amounts – Continued
The following tables summarize the percentage change in the 2021 results compared to the 2020 results for the corresponding periods.
|
Three Months Ended December 31,
|
||||||||||||||||
|
Revenue
|
Total
|
Foreign Exchange Rates
|
Adjustments (2)
|
Adjusted Local Currency
|
||||||||||||
|
Flavors & Extracts
|
(6.1%)
|
(0.7%)
|
(13.4%)
|
8.0%
|
||||||||||||
|
Color
|
14.4%
|
(1.1%)
|
(0.3%)
|
15.8%
|
||||||||||||
|
Asia Pacific
|
11.1%
|
(3.5%)
|
(0.4%)
|
15.0%
|
||||||||||||
|
Total Revenue
|
1.7%
|
(1.2%)
|
(7.8%)
|
10.7%
|
||||||||||||
|
Operating Income
|
||||||||||||||||
|
Flavors & Extracts
|
(6.7%)
|
(0.7%)
|
(16.6%)
|
10.6%
|
||||||||||||
|
Color
|
17.3%
|
(0.8%)
|
(1.0%)
|
19.1%
|
||||||||||||
|
Asia Pacific
|
18.9%
|
(5.1%)
|
(0.9%)
|
24.9%
|
||||||||||||
|
Corporate & Other
|
(16.1%)
|
0.0%
|
(38.2%)
|
22.1%
|
||||||||||||
|
Total Operating Income
|
16.1%
|
(1.8%)
|
3.3%
|
14.6%
|
||||||||||||
|
Diluted Earnings Per Share
|
10.2%
|
(1.7%)
|
(9.4%)
|
21.3%
|
||||||||||||
|
Adjusted EBITDA
|
13.5%
|
|
(1.2%)
|
N/A
|
14.7%
|
|
||||||||||
|
Year Ended December 31,
|
||||||||||||||||
|
Revenue
|
Total
|
Foreign Exchange Rates
|
Adjustments (2)
|
Adjusted Local Currency
|
||||||||||||
|
Flavors & Extracts
|
(0.4%)
|
|
1.6%
|
(11.4%)
|
9.4%
|
|||||||||||
|
Color
|
8.8%
|
|
2.1%
|
(2.7%)
|
9.4%
|
|||||||||||
|
Asia Pacific
|
11.6%
|
1.7%
|
(0.2%)
|
10.1%
|
||||||||||||
|
Total Revenue
|
3.6%
|
1.8%
|
(7.3%)
|
9.1%
|
||||||||||||
|
Operating Income
|
||||||||||||||||
|
Flavors & Extracts
|
8.4%
|
1.2%
|
(8.0%)
|
15.2%
|
||||||||||||
|
Color
|
7.9%
|
2.6%
|
0.5%
|
4.8%
|
||||||||||||
|
Asia Pacific
|
19.3%
|
(1.8%)
|
(0.5%)
|
21.6%
|
||||||||||||
|
Corporate & Other
|
3.7%
|
0.0%
|
(18.4%)
|
22.1%
|
||||||||||||
|
Total Operating Income
|
11.4%
|
2.1%
|
1.0%
|
8.3%
|
||||||||||||
|
Diluted Earnings Per Share
|
8.5%
|
1.9%
|
(3.4%)
|
10.0%
|
||||||||||||
|
Adjusted EBITDA
|
10.6%
|
2.0%
|
|
N/A
|
8.6%
|
|||||||||||
| (2) |
For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product
lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment.
|
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three and twelve months ended December 31, 2021 and 2020.
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||||||||||
|
2021
|
2020
|
% Change
|
2021
|
2020
|
% Change
|
|||||||||||||||||||
|
Operating income (GAAP)
|
$
|
40,420
|
$
|
34,815
|
16.1%
|
|
$
|
170,028
|
$
|
152,656
|
11.4%
|
|
||||||||||||
|
Depreciation and amortization
|
13,223
|
12,810
|
52,051
|
49,641
|
||||||||||||||||||||
|
Depreciation and amortization, divested product lines
|
-
|
(48
|
)
|
(146
|
)
|
(193
|
)
|
|||||||||||||||||
|
Share-based compensation expense
|
3,142
|
1,591
|
9,573
|
5,608
|
||||||||||||||||||||
|
Divestiture & other related costs, before tax
|
637
|
1,675
|
14,138
|
12,155
|
||||||||||||||||||||
|
Results of operations of the divested product lines, before tax
|
518
|
(3,415
|
)
|
(1,880
|
)
|
(7,580
|
)
|
|||||||||||||||||
|
Operational improvement plan costs (income), before tax
|
115
|
698
|
(1,895
|
)
|
3,339
|
|||||||||||||||||||
|
COVID-19 employee payment, before tax
|
-
|
3,022
|
-
|
3,022
|
||||||||||||||||||||
|
Adjusted EBITDA
|
$
|
58,055
|
$
|
51,148
|
13.5%
|
|
$
|
241,869
|
$
|
218,648
|
10.6%
|
|
||||||||||||
The following table summarizes the reconciliation between Net cash provided by operating activities (GAAP) and Free Cash Flow for the three and twelve months ended December
31, 2021 and 2020.
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||||||||||
|
2021
|
2020
|
% Change
|
2021
|
2020
|
% Change
|
|||||||||||||||||||
|
Net cash provided by operating activities (GAAP)
|
$
|
29,070
|
$
|
75,853
|
(61.7
|
%)
|
$
|
145,218
|
$
|
218,780
|
(33.6
|
%)
|
||||||||||||
|
Capital expenditures
|
(23,180
|
)
|
(18,153
|
)
|
(60,788
|
)
|
(52,162
|
)
|
||||||||||||||||
|
Free Cash Flow
|
$
|
5,890
|
$
|
57,700
|
(89.8
|
%)
|
$
|
84,430
|
$
|
166,618
|
(49.3
|
%)
|
||||||||||||
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period
performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should
be considered together with GAAP measures and the rest of the information included in this release and our SEC filings. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and
to gain additional insight into underlying operating and performance trends, and we believe the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other
companies.
Exhibit 99.2
Fourth Quarter 2021 Investor Presentation
FORWARD-LOOKING STATEMENTS 2 This document contains statements that may constitute
“forward-looking statements” within the meaning of Federal securities laws including under “2022 Financial Outlook” in this presentation. Such forward-looking statements are not guarantees of future performance and involve known and unknown
risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could
adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and
suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation, governmental regulations and restrictions, and general economic conditions, including
inflation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to
successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s
past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and
disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the
Company's Annual Report on Form 10-K for the year ended December 31, 2020, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and
uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have
material adverse effects on our business, financial condition, and results of operations. This presentation contains time-sensitive information that reflects management’s best analysis only as of the date of this presentation. Except to the
extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be
realized.
NON-GAAP FINANCIAL MEASURES 2 Within this document, the Company reports certain non-GAAP financial
measures, including: (1) adjusted revenue, adjusted operating income, adjusted net earnings, adjusted EBITDA, and adjusted diluted earnings per share (which exclude divestiture & other related costs, the results of the divested product
lines, restructuring and other costs, which include operational improvement plan costs and income, and the 2020 one-time COVID-19 employee payment) (2) adjusted results by segment (which exclude divestiture & other related costs,
operational improvement plan costs and income, and the results of the divested operations), (3) percentage changes in revenue, operating income, diluted earnings per share, and EBITDA on an adjusted local currency basis (which eliminate the
effects that result from translating its international operations into U.S. dollars, divestiture & other related costs, the results of the divested product lines, restructuring and other costs, which include operational improvement plan
costs, and the 2020 one-time COVID-19 employee payment), and (4) adjusted EBITDA (which excludes depreciation and amortization expense, non-cash share based compensation expense, the results of the divested product lines, the divestiture &
other related costs, operational improvement plan costs and income, and the 2020 one-time COVID-19 employee payment). The Company has included each of these non-GAAP measures in order to provide additional information regarding the underlying
operating results and comparable period- over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures
should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this presentation and the Company’s SEC filings. Management internally reviews each of these
non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends. The Company believes this information can be beneficial to investors for these
same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies. Refer to “Non-GAAPFinancial Measures” at the end of this presentation for reconciliations and additional information.
Sensient Overview 2 Provider of customized solutions for food and beverage, pharmaceutical, and
personal care customersGlobal market leader offering an extensive portfolio of natural flavor and color technology platforms and solutionsExceptional innovation & applications expertise with unique ability to service global, regional, and
local customers
Innovative Technologies Creating Unique Solutions 2 Applications expertise and solutions-based
sellingHigh impact relative to costTechnically-driven products that are difficult to replace Strong consumer trendsOpportunities to grow organically and through M&A
Focusing our portfolio and strengthening our commitment to the end markets 2 Investing in core
focus areas of Flavors and Extracts, Natural Ingredients, Food and Pharmaceutical Colors, and Personal CareDivested non-core product lines (inks, fragrances, and yogurt fruitprep product lines) in 2020 and 2021Expanded flavor portfolio and
strengthened technical solutions capabilities through the acquisition of Flavor Solutions, Inc. on July 15, 2021
Natural solutions provider focused on consistent and sustainable supply chain 2 Provider of natural
solutions to support health & wellness and clean label consumer trendsRobust agronomy program ensures responsible procurement and traceability of sustainable ingredientsCommitted to delivering safe, authentic, high-quality natural products
through Sensient’s CertasureTM program
8 Color Group2021 Revenue: $545M 2021 Adj. Revenue*: $543M Core Areas of Focus: Food and
Pharmaceutical Colors and Personal CareFlavors & Extracts Group2021 Revenue: $739M 2021 Adj. Revenue*: $712M Core Areas of Focus: Natural Flavors, Extracts and Natural IngredientsAsia Pacific Group2021 Revenue: $135M 2021 Adj. Revenue*:
$135M Core Areas of Focus: Flavors and Colors for food and beverage Global Revenue by Group 2021 Global Revenues include intercompany sales which are eliminated on a consolidated basis.*Adj. Revenue is a Non-GAAP metric, please see our GAAP
to Non-GAAP Reconciliation at the end of this document.
9 Global market leaderNatural color innovatorExcellent innovation & applications
expertise Color Group
10 Color Overview Food and Pharmaceutical 71% of Segment Revenue 71% of Adj. Segment Revenue LC
Revenue ChangeQ4 ’21 +15.6%YTD ’21 +9.4% Market trend toward natural colors in food and beverageUnique value proposition for Pharmaceutical customers includescolors, flavors, coatings, and extracts Personal Care 29% of Segment Revenue 29% of
Adj. Segment Revenue LC Revenue ChangeQ4 ’21 +16.3%YTD ’21 +9.3% Demand for innovative products with multiple benefitsProduct line includes formulation aides and ingredients for colorcosmetics, hair care, and skin careRecovery from
negative COVID impacts ongoing Inks Inks divested in June 2020 2021 Revenue: $545M 2021 Adj. Revenue*: $543M *Local-currency (LC) revenue and adjusted revenue are Non-GAAP metrics, please see our GAAP to Non- GAAP Reconciliation at
the end of this document.
11 Flavors & Extracts Group Broad product offeringUnique ability to service global, regional, and
local customersLeading technology platformsOutstanding applications expertise
12 Flavors & Extracts Overview Flavors, Extracts, and Flavor Ingredients 62% of Segment Revenue
64% of Adj. Segment Revenue LC Revenue Change Q4 ’21 +11.8%YTD ’21 +11.9% Opportunities for on trend products with extracts, taste modulation, and natural flavors NaturalIngredients 35% of Segment Revenue 36% of Adj. Segment
Revenue LC Revenue ChangeQ4 ’21 +2.4%YTD ’21 +5.1% Leading provider of dehydrated onion, garlic, and other products Fragrances & Yogurt Fruit Prep 3% of Segment Revenue Yogurt Fruit Prep divested September 2020Fragrances divested
April 2021 2021 Revenue: $739M 2021 Adj. Revenue*: $712M *Local-currency (LC) revenue and adjusted revenue are Non-GAAP metrics, please see our GAAP to Non- GAAP Reconciliation at the end of this document.
13 Asia Pacific Group Portfolio of food and beverage flavors and colorsR&D centers in Singapore,
Thailand, and China to support local and regional customer baseAbility to deliver localized solutionsand technology platforms
14 2021 adjusted revenue of $135 million and adjusted operating income of $26 millionSensient’s
sales of flavors and colors for Food and Pharmaceutical are managed on a geographic basis and reported as a separate segmentManufacturing capabilities in Australia, New Zealand, China, Japan, Philippines, Thailand, and IndiaQ4 2021 local
currency adjusted revenue and operating profit improved15.0% and 24.9%, respectively * Adjusted revenue, local currency adjusted revenue, adjusted operating income, and local currency adjusted operating income are Non-GAAP metrics. Please see
our GAAP to Non-GAAP Reconciliation at the end of this document. Asia Pacific Overview
15 2021 Q4 Segment Results Local Currency Adjusted Revenue* Local Currency Adjusted*
Commentary: Q4 YTD Color Group reported higher revenue in the quarter due to double digit growth in Personal Care and continued strength in Food and Pharmaceutical driven by new product launches and demand in natural food and beverage
colors. Operating income was up in the quarter due to volume. Color +15.8% +9.4% Flavors & Extracts +8.0% +9.4% Asia Pacific +15.0% +10.1% Flavors & Extracts Group fourth quarter revenue increase was driven by volume
growth in all product categories. Flavor Solutions acquisition contributed $3 million, or 1.9%, of growth in the quarter. Operating income was up as a result of the higher volumes and product mix.Asia Pacific Group fourth quarter revenue
increased double digits driven by volume growth in almost all regions. Operating income improved in the quarter due to volume growth. Local Currency Adjusted OperatingIncome* Q4 YTD Color +19.1% +4.8% Flavors &
Extracts +10.6% +15.2% Asia Pacific +24.9% +21.6% * Local-currency (LC) adjusted revenue and adjusted operating income are Non-GAAP metrics. Please see our GAAP to Non-GAAP Reconciliation at the end of this document.
16 2021 Q4 Consolidated Results Q4 YTD Local Currency Adjusted Revenue* +10.7% +9.1% Local
Currency Adjusted Operating Income* +14.6% +8.3% Local Currency Adjusted Diluted EPS* +21.3% +10.0% Local Currency Adjusted EBITDA* +14.7% +8.6% Q4 consolidated local currency adjusted revenue was up double digits due to strong growth
across all of the groups primarily as a result of volume growth driven by new customer sale wins. Personal Care revenue grew double digits driven by the group’s diversification strategy and ongoing recovery in color make-up.Q4 consolidated
local currency adjusted operating income was up due to the overall volume growth across our businesses; however, the operating income improvement was partially offset due to higher year-over-year Corporate expenses related to performance-based
compensation and timing of pricing actions related to higher raw material costs. * Local-currency (LC) adjusted revenue, adjusted operating income, adjusted diluted EPS, and adjusted EBITDA are Non-GAAP metrics. Please see our GAAP to Non-GAAP
Reconciliation at the end of this document.
Capital Allocation Prioritize ROI capital projects Maintain financial flexibility to
pursueM&A Dividend payout increased 5.1% in 2021 Excess capital returned to shareholdersthrough opportunistic share
repurchases $87 $77 $43 $54 $57 $62 $66 $67 $56 $51 $39 $52 $61 $31 $14 $9 $87 $118 $- $50 $100 $150 $200 $250 2017 2018 2019 2020 2021 DOLLARS IN MILLIONS Share
Repurchase Acquisitions Dividends Debt Repayments Capital Expenditures 17
2022 Financial Outlook 18 Metric Guidance* Comments Diluted EPS (GAAP) Mid-teen growth At
current rates, we anticipate a FX headwind of approximately 10 cents Local Currency Diluted EPS* High single digit growth Local Currency Revenue* Mid-single digit growth Adjusted Local Currency EBITDA* High single digit
growth Excludes the impact of share-based stock compensation *In 2022, the Company does not anticipate any impact to the above metrics as a result of divestiture & other related costs, operational improvement plancosts, or the results of
the divested operations.The 2022 Local Currency Diluted EPS, Local Currency Revenue and Adjusted Local Currency EBITDA growth rates for 2022 are compared to the 2021 Adjusted Diluted EPS, Adjusted Revenue and Adjusted EBITDA, respectively,
which excluded the divestiture & other related costs, operational improvement plan costs and the results of operations of the divested product lines. Adjusted revenue, adjusted diluted EPS and adjusted EBITDA are Non-GAAP metrics. Please
see our GAAP to Non-GAAP Reconciliation at the end of this document.
Why Invest? Strong competitive positionDefensible and ‘Sticky’ business (& low portion
ofcustomer costs)Global presenceExposure to stable and growing markets Focused on improving returns and on growth 19
APPENDIX* *Amounts in thousands, except percentages and per share amounts
ESG Information Click here to access our Environmental Sensient is committed to the principles of
sound environmental stewardship and the responsible and sustainable use of energy and natural resources.Long-term goals to reduce Energy, Water, and Hazardous Waste intensitySeed-to-shelf program focused on sustainable supply chainEmphasis on
new products and technologies that minimize waste and environmental impactsChemical Risk Strategy implemented to identify and reduce risk in our portfolio Social Sensient strives to conduct business in an ethical manner and to make a positive
contribution to society through our product offerings and business activities.Sensient’s Code of Conduct and Supplier Code of Conduct require strong ethical behavior, fair employment practices, and strict human rights practices and product
safety standardsRobust product, environmental, and raw material safety programs designed to exceed industry standards.Raw material traceability and sustainability programsSupport for our local communities through volunteerism, financial
donations, sponsorships, and employee education opportunities Governance Sensient is committed to maintaining the highest standards of professional conduct and strong corporategovernance practices through our comprehensive corporate
governance framework.Board comprised of a majority of independent directors with diverse and accomplished backgroundsCommitted to board diversity and refreshment, we were recognized by 50/50 Women on Boards for the tenth year in a row and we
have added seven new directors since 2014.Robust Code of Conduct built on a foundation of ethics, safety and quality, and professionalism resulting in ethical and lawful conduct of our business 21
22 Non-GAAP Financial Measures Note: EPS Calculations may not foot due to rounding differences Three
Months Ended December 31, 2021$ 340,448 Year Ended December 31, 2021 Year Ended December 31, 2020$ 1,332,001 Revenue (GAAP) 1,380,264 Three Months Ended December 31, 2020$ 334,668 $ Revenue of the divested product lines (663)
(25,163) (30,062) (113,553) Adjusted revenue $ 339,785 $ 309,505 $ 1,350,202 $ 1,218,448 Operating income (GAAP) $ 40,420 $ 34,815 $ 170,028 $ 152,656 Divestiture & other related costs (income) –
Cost of products sold 58 4 86 1,795 Divestiture & other related costs – Selling and administrative expenses 579 1,671 14,052 10,360 Operating loss (income) of the divested product
lines 518 (3,415) (1,880) (7,580) Operational improvement plan - Cost of products sold - - - 35 Operational improvement plan - Selling and administrative expenses (income) 115 698 (1,895) 3,304 COVID-19
employee payment - Cost of products sold - 1,036 - 1,036 COVID-19 employee payment - Selling and administrative expenses - 1,986 - 1,986 Adjusted operating income $ 41,690 $ 36,795 $ 180,391 $
163,592 Net earnings (GAAP) $ 27,229 $ 25,169 $ 118,745 $ 109,472 Divestiture & other related costs, before tax 637 1,675 14,138 12,155 Tax impact of divestiture & other related
costs 1,809 (1,393) 2,092 (2,605) Net loss (earnings) of the divested product lines, before tax 518 (3,415) (1,880) (7,580) Tax impact of the divested product lines (130) 790 460 1,945 Operational
improvement plan costs (income), before tax 115 698 (1,895) 3,339 Tax impact of operational improvement plan 427 (170) 471 (826) COVID-19 employee payment, before tax - 3,022 - 3,022 Tax impact of COVID-19
employee payment - (675) - (675) Adjusted net earnings $ 30,605 $ 25,701 $ 132,131 $ 118,247 Diluted earnings per share (GAAP) $ 0.65 $ 0.59 $ 2.81 $ 2.59 Divestiture & other related costs
(income), net of tax 0.06 0.01 0.38 0.23 Results of operations of the divested product lines, net of tax 0.01 (0.06) (0.03) (0.13) Operational improvement plan costs (income), net of
tax 0.01 0.01 (0.03) 0.06 COVID-19 employee payment, net of taxAdjusted diluted earnings per share - 0.06 - 0.06 $ 0.73 $ 0.61 $ 3.13 $ 2.79
Non-GAAP Financial Measures (Cont’d) 23 Revenue Total ForeignExchange Rates
Adjustments* AdjustedLocal Currency Total ForeignExchange Rates Adjustments* AdjustedLocal Currency Flavors &
Extracts (6.1%) (0.7%) (13.4%) 8.0% (0.4%) 1.6% (11.4%) 9.4% Color 14.4% (1.1%) (0.3%) 15.8% 8.8% 2.1% (2.7%) 9.4% Asia Pacific 11.1% (3.5%) (0.4%) 15.0% 11.6% 1.7% (0.2%) 10.1% Total
Revenue 1.7% (1.2%) (7.8%) 10.7% 3.6% 1.8% (7.3%) 9.1% Operating IncomeFlavors & Extracts (6.7%) (0.7%) (16.6%) 10.6% 8.4% 1.2% (8.0%) 15.2% Color 17.3% (0.8%) (1.0%) 19.1% 7.9% 2.6% 0.5% 4.8% Asia
Pacific 18.9% (5.1%) (0.9%) 24.9% 19.3% (1.8%) (0.5%) 21.6% Corporate & Other (16.1%) 0.0% (38.2%) 22.1% 3.7% 0.0% (18.4%) 22.1% Total Operating Income 16.1% (1.8%) 3.3% 14.6% 11.4% 2.1% 1.0% 8.3% Diluted Earnings
Per Share 10.2% (1.7%) (9.4%) 21.3% 8.5% 1.9% (3.4%) 10.0% Adjusted EBITDA 13.5% (1.2%) N/A 14.7% 10.6% 2.0% N/A 8.6% * For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted
Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment. Three
Months Ended December 31, 2021 Year Ended December 31, 2021
Non-GAAP Financial Measures (Cont’d) 24 2021 2020 % Change 2021 2020 % Change
Operating income (GAAP) $ 40,420 $ 34,815 16.1% $ 170,028 $ 152,656 11.4% Depreciation and amortization 13,223 12,810 52,051 49,641 Depreciation and amortization, divested product lines - (48) (146) (193) Share-based
compensation expense 3,142 1,591 9,573 5,608 Divestiture & other related costs, before tax 637 1,675 14,138 12,155 Results of operations of the divested product lines, before
tax 518 (3,415) (1,880) (7,580) Operational improvement plan costs (income), before tax 115 698 (1,895) 3,339 COVID-19 employee payment, before tax - 3,022 - 3,022 Adjusted EBITDA $ 58,055 $ 51,148
13.5% $ 241,869 $ 218,648 10.6% Three Months Ended December 31, Year Ended December 31,
Non-GAAP Financial Measures (Cont’d) 25 Note: *Fragrances was divested in April 2021, Inks was divested
in June 2020, and Yogurt Fruit Prep was divested in September 2020. Revenue Total Exchange Rates Local Currency Total Exchange Rates Local Currency Flavors, Extracts and Flavor
Ingredients 11.2% (0.6%) 11.8% 14.1% 2.2% 11.9% Natural Ingredients 2.4% 0.0% 2.4% 5.2% 0.1% 5.1% Fragrances* (100.0%) (4.0%) (96.0%) (73.4%) 3.7% (77.1%) Yogurt Fruit
Prep* (90.3%) 0.0% (90.3%) (64.1%) 0.0% (64.1%) Flavors & Extracts Group (6.1%) (0.7%) (5.4%) (0.4%) 1.6% (2.0%) Food and Pharmaceutical 14.6% (1.0%) 15.6% 11.5% 2.1% 9.4% Personal
Care 15.0% (1.3%) 16.3% 11.5% 2.2% 9.3% Inks* (22.5%) 0.0% (22.5%) (85.4%) 1.8% (87.2%) Color Group 14.4% (1.1%) 15.5% 8.8% 2.1% 6.7% Asia Pacific 11.1% (3.5%) 14.6% 11.6% 1.7% 9.9% Total revenue including the
productlines divested 1.7% (1.2%) 2.9% 3.6% 1.7% 1.9% Three Months Ended December 31, 2021 Year Ended December 31, 2021 Foreign Foreign
Q4 Results of Operations 26 Results by Segment Three Months Ended December 31, Revenue 2021
Adjustments* Adjusted 2021 2020 Adjustments* Adjusted 2020 Flavors & Extracts $ 177,448 $ (221) $ 177,227 $ 189,060 $ (24,378) $ 164,682 Color 137,104 (442) 136,662 119,813 (766) 119,047 Asia
Pacific 35,749 - 35,749 32,165 (116) 32,049 Intersegment elimination (9,853) - (9,853) (6,370) 97 (6,273) Consolidated $ 340,448 $ (663) $ 339,785 $ 334,668 $ (25,163) $ 309,505 Operating
Income Flavors & Extracts $ 21,942 $ 491 $ 22,433 $ 23,507 $ (3,214) $ 20,293 Color 24,113 27 24,140 20,548 (158) 20,390 Asia Pacific 7,184 - 7,184 6,044 (43) 6,001 Corporate & Other (12,819) 752
(12,067) (15,284) 5,395 (9,889) Consolidated $ 40,420 $ 1,270 $ 41,690 $ 34,815 $ 1,980 $ 36,795 * For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist
of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment.
Q4 YTD Results of Operations 27 Results by Segment Year Ended December 31, Revenue 2021
Adjustments* Adjusted 2021 2020 Adjustments* Adjusted 2020 Flavors & Extracts $ 739,427 $ (27,837) $ 711,590 $ 742,035 $ (99,543) $ 642,492 Color 545,270 (2,080) 543,190 501,018 (14,008) 487,010 Asia
Pacific 135,348 (295) 135,053 121,227 (518) 120,709 Intersegment elimination (39,781) 150 (39,631) (32,279) 516 (31,763) Consolidated $ 1,380,264 $ (30,062) $ 1,350,202 $ 1,332,001 $ (113,553) $ 1,218,448
Operating Income Flavors & Extracts $ 98,660 $ (2,368) $ 96,292 $ 90,974 $ (8,292) $ 82,682 Color 103,575 575 104,150 96,034 871 96,905 Asia Pacific 26,330 (87) 26,243 22,075 (159) 21,916 Corporate &
Other (58,537) 12,243 (46,294) (56,427) 18,516 (37,911) Consolidated $ 170,028 $ 10,363 $ 180,391 $ 152,656 $ 10,936 $ 163,592 * For Revenue, adjustments consist of revenues of the divested product lines. For
Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment.
28